Dongfang Liu, PhD recently joined the Department of Pathology and Laboratory Medicine and the Center for Immunity and Inflammation as an Associate Professor. In 2012, Dr. Liu was recruited to Baylor College of Medicine as a tenure-track Assistant Professor in the Department of Pediatrics and Department of Pathology & Immunology, before joining Houston Methodist Hospital (a teaching hospital affiliated with Weill Cornell Medical College) as an assistant professor in 2015. In 2018, Dr. Liu was promoted to an Associate Professor in Houston Methodist Research Institute. Dr. Liu did his postdoctoral training on natural killer (NK) cells at the National Institute of Allergy and Infectious Diseases (NIAID) in National Institutes of Health (NIH) from 2005 to 2011. After completing the postdoctoral training, he joined Ragon Institute of MGH, MIT and Harvard in 2011 as a senior research scientist, where he worked on HIV-specific CTL dysfunction with a focus on PD-1 in HIV-specific CTLs. Dr. Liu?s current research is primarily focused on the immunobiology of chimeric antigen receptor (CAR) T and NK cells, immunoreceptors, CAR immunotherapy, and HIV-specific CTLs in chronic HIV and its related malignancies, with a focus on immunological synapse biology and its clinical applications. Dr. Liu?s research is supported by several NIH grants, including an RO1 and three R21 grants.
PHD, 2005, Huazhong University of Science and Technology, Hubei, China
MBBS, 2001, Wuhan University School of Medicine, Hubei, China
Curriculum VitaeView CV